Blog | Health Care Dialogue

Take aways - building your Leadership Branding

Rachel Ougier Simonin

Mar 131 min read

Take aways - building your Leadership Branding

Thank you to Shivangi Walke for sharing the key highlights of her Listen & Learn in February 2024!

18 views0 comments

Rachel Ougier Simonin

Mar 71 min read

US pricing: parity between biologics and small molecules

https://www.biospace.com/article/stakeholders-hope-bill-will-create-ira-drug-negotiation-parity-between-biologics-and-small-molecules-/

5 views0 comments

Rachel Ougier Simonin

Mar 61 min read

Biotech IPO venture funding outlook for 2024

https://www.biopharmadive.com/news/biotech-ipo-venture-funding-outlook-2024/709084/?utm_source=Sailthru&utm_medium=email&utm_campaign=Iss...

9 views0 comments

Rachel Ougier Simonin

Mar 51 min read

Insights for Healthcare Innovators

What are the first health care applications of quantum computing? Listen to the great conversation with Frederik Floether on the Care...

4 views0 comments

Rachel Ougier Simonin

Mar 51 min read

Is 2024 the year of Lean fractional C-Suites?

https://www.biospace.com/article/is-2024-the-year-of-lean-fractional-c-suites-/

4 views0 comments

Rachel Ougier Simonin

Mar 41 min read

US and EU Healthcare market update (from Back Bay)

https://us4.campaign-archive.com/?e=%5BUNIQID%5D&u=e2b9105c5aab455a12293b45e&id=51a2377265

0 views0 comments

Rachel Ougier Simonin

Mar 21 min read

Judge denies AstraZeneca’s lawsuit against Medicare negotiation

https://thehill.com/policy/healthcare/4501552-judge-denies-astrazenecas-lawsuit-against-medicare-negotiation/

5 views0 comments

Rachel Ougier Simonin

Feb 291 min read

2024 will be a buyers’ market in Biopharma

https://www.biospace.com/article/opinion-2024-will-be-a-buyers-market-in-biopharma-it-already-is/

4 views0 comments

Rachel Ougier Simonin

Feb 261 min read

Getting genes therapies into the fast lane

With a rich pipeline of hundreds of candidate therapeutics in all phases of clinical development and evaluation, across all platform...

6 views0 comments

Rachel Ougier Simonin

Feb 81 min read

Generative AI in the Pharma Industry (McKinsey)

https://www.mckinsey.com/industries/life-sciences/our-insights/generative-ai-in-the-pharmaceutical-industry-moving-from-hype-to-reality?s...

2 views0 comments

Rachel Ougier Simonin

Feb 51 min read

Revenue loss due to patent expirations

https://www.cnbc.com/2024/01/28/big-pharma-merck-bristol-myers-jj-prepare-to-lose-revenue.html

2 views0 comments

Rachel Ougier Simonin

Feb 21 min read

Swiss Ventures Capital report 2024

https://www.startupticker.ch/en/swiss-venture-capital-report

3 views0 comments

Rachel Ougier Simonin

Feb 11 min read

Women’s health gap & Economics - McKinsey report

https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies

1 view0 comments

Rachel Ougier Simonin

Jan 291 min read

IPO forecasts - 2024

https://www.fiercebiotech.com/biotech/cgs-and-arrivents-oversized-ipos-bode-well-2024-after-dreary-year

5 views0 comments

Rachel Ougier Simonin

Jan 191 min read

5 questions Pharma faces in 2024

https://www.biopharmadive.com/news/pharma-outlook-2024-obesity-cancer-ira-alzheimers/704138/

2 views0 comments

Rachel Ougier Simonin

Jan 181 min read

Ventures Healthcare report 2023

https://www.hsbcinnovationbanking.com/en-gb/venture-healthcare-report

1 view0 comments

Rachel Ougier Simonin

Jan 171 min read

1 visual about Healthcare in Basel

https://invest.baselarea.swiss//wp-content/uploads/sites/3/2023/05/Life-Science-infographic_web-2.jpg.webp

9 views0 comments

Rachel Ougier Simonin

Jan 171 min read

Basel life sciences sector is the most productive in the world

https://baselarea.swiss/blog-post/basel-life-sciences-sector-is-the-most-productive-in-the-world/

1 view0 comments

Rachel Ougier Simonin

Jan 171 min read

BASEL IS “PROBABLY THE MOST PRODUCTIVE LIFE SCIENCES LOCATION IN THE WORLD”

https://www.s-ge.com/en/article/news/20203-life-science-most-productive-life-sciences-location?ct

6 views0 comments

Rachel Ougier Simonin

Nov 6, 20231 min read

Diadem announces U.S. Licensing Agreement with Quest Diagnostics for Alzheimer's Disease Prognostic

https://www.biospace.com/article/releases/diadem-spa-announces-exclusive-u-s-licensing-agreement-with-quest-diagnostics-for-its-alzosure-...

1 view0 comments